Doxorubicin and Bortezomib in Treating Patients With Liver Cancer

Clinical trial NCT00083226 · COMPLETED

Trial details

NCT number: NCT00083226
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Adult Primary Hepatocellular Carcinoma Advanced Adult Primary Liver Cancer Localized Unresectable Adult Primary Liver Cancer Recurrent Adult Primary Liver Cancer

Start date: 2004-03-01
Primary completion: 2011-02-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.